Alterations in Mitochondrial Function in Pulmonary Vascular Diseases
Antioxidants & Redox Signaling · 2025-03 · 42 (7-9) · 361-377
DOI: 10.1089/ars.2024.0557 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, online erschienen am 07.03.2025. Verfasst von Samar Farha und 25 weiteren Autor:innen. Beteiligte Einrichtung: Integrated Hospital-Care Institute, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Mitochondria, Hypertension, Pulmonary. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Aims
Alterations of mitochondrial bioenergetics and arginine metabolism are universally present and mechanistically linked to pulmonary arterial hypertension (PAH), but there is little knowledge of arginine metabolism and mitochondrial functions across the different pulmonary hypertension (PH) groups. We hypothesize that abnormalities in mitochondrial functions are present across all PH groups and associated with clinical phenotypes. We test the hypothesis in PH patients and healthy controls from the Pulmonary Vascular Disease Phenomics Program cohort, who had comprehensive clinical phenotyping and follow-up for at least 4 years for death or transplant status. Mitochondrial transmembrane potential, superoxide production, and mass were measured by flow cytometry in fresh platelets. Metabolomics analysis was performed on plasma samples. Global arginine bioavailability was calculated as the ratio of arginine/(ornithine+citrulline).
Results
Global arginine bioavailability is consistently lower than controls in all PH groups. Although the mitochondrial mass is similar across all PH groups and controls, superoxide production and transmembrane potential vary across groups. Mitochondrial superoxide is higher in group 1 PAH and lowest in group 3 compared with other groups, while transmembrane potential is lower in group 1 PAH than controls or group 3. The alterations in mitochondrial functions of group 1 PAH are associated with changes in fatty acid metabolism. Mitochondrial transmembrane potential in group 1 PAH is associated with transplant-free survival.
Conclusion
While alterations in mitochondrial function are found in all PH groups, group 1 PAH has a unique mitochondrial phenotype with greater superoxide and lower transmembrane potential linked to fatty acid metabolism, and clinically to survival. Antioxid. Redox Signal. 42, 361–377.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Integrated Hospital-Care Institute, Cleveland Clinic, Cleveland, Ohio, USA.
- Lerner Research Institute, Cleveland Clinic, Ohio, USA.
- Division of Pulmonary and Critical Care Medicine, Johns Hopkins Hospital, Baltimore, Maryland, USA.
- Department of Medicine, Indiana University School of Medicine Indianapolis, Indianapolis, Indiana, USA.
- Department of Pediatrics and Medicine, Columbia University, New York, New York, USA.
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Samar Farha
Förderung
- NHLBI NIH HHS
Zitieren
APA
Farha, S., Asosingh, K., Hassoun, P. M., Barnard, J., Comhair, S., Reichard, A., Wanner, N., Radeva, M., Aldred, M. A., Beck, G. J., Berman-Rosenzweig, E., Borlaug, B. A., Finet, J. E., Frantz, R. P., Grunig, G., Hemnes, A. R., Hill, N., Horn, E. M., Jellis, C., …, & PVDOMICS Study Group (2025). Alterations in Mitochondrial Function in Pulmonary Vascular Diseases. Antioxidants & Redox Signaling, 42(7-9), 361-377. https://doi.org/10.1089/ars.2024.0557
Vancouver
Farha S, Asosingh K, Hassoun PM, Barnard J, Comhair S, Reichard A, et al. Alterations in Mitochondrial Function in Pulmonary Vascular Diseases. Antioxidants & Redox Signaling. 2025;42(7-9):361-377. doi:10.1089/ars.2024.0557
BibTeX
@article{Farha2025,
author = {Farha, Samar and Asosingh, Kewal and Hassoun, Paul M and Barnard, John and Comhair, Suzy and Reichard, Andrew and Wanner, Nicholas and Radeva, Milena and Aldred, Micheala A and Beck, Gerald J and Berman-Rosenzweig, Erika and Borlaug, Barry A and Finet, J Emanuel and Frantz, Robert P and Grunig, Gabriele and Hemnes, Anna R and Hill, Nicholas and Horn, Evelyn M and Jellis, Christine and Leopold, Jane A and Mehra, Reena and Park, Margaret M and Rischard, Franz P and Tang, W H Wilson and Erzurum, Serpil C and PVDOMICS Study Group, PVDOMICS Study Group},
title = {Alterations in Mitochondrial Function in Pulmonary Vascular Diseases},
journal = {Antioxidants & Redox Signaling},
year = {2025},
volume = {42},
number = {7-9},
pages = {361--377},
doi = {10.1089/ars.2024.0557}
}
EUVIMED